WGS of Mycobacterium tuberculosis from a phase2b study on vaccine H56:IC31
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
A phase 2b, double-blind, randomised, placebo-controlled study to evaluate the immunogenicity, safety and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis
创建时间：
2025-03-06
